Frequent T cell responses against immunogenic targets in lung cancer patients for targeted immunotherapy

Author：

ISSN： 1021-335X

Source： Oncology Reports, Vol.31, Iss.1, 2014-01, pp. : 384-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Monitoring T Cell Responses to Cancer Immunotherapy: Can We Now Identify Biomarkers Predicting Patients Who will be Responders

Current Cancer Therapy Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 111-119

Bentham Science Publishers

Access to resources Recommend Favorite

A peptide antigen derived from EGFR T790M is immunogenic in nonsmall cell lung cancer

International Journal of Oncology, Vol. 46, Iss. 2, 2015-01 ,pp. : 497-504

Spandidos Publications

Access to resources Recommend Favorite

Recent Advances in T Cell Adoptive Immunotherapy of Cancer

Current Cancer Therapy Reviews, Vol. 4, Iss. 1, 2008-02 ,pp. : 1-13

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted therapies in small cell lung cancer (Review)

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 3-11

Spandidos Publications

Access to resources Recommend Favorite

Effect of hydrothorax EGFR gene mutation and EGFRTKI targeted therapy on advanced nonsmall cell lung cancer patients

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1413-1417

Spandidos Publications

Access to resources Recommend Favorite